The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

NCT03402048 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

567

Enrollment

OTHER

Sponsor class

Conditions

Stage IV, NSCLC
Lung Neoplasms
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

Interventions

DRUG: Carboplatin
DRUG: Gemcitabine
DRUG: Pemetrexed
DRUG: Docetaxel
DRUG: Vinorelbine

Sponsor

University of Turin, Italy